D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus
- 1 November 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 3 (6), 1628-1636
- https://doi.org/10.2215/cjn.01480308
Abstract
Background and objectives: Patients who have systemic lupus erythematosus (SLE) and manifest antiphospholipid antibodies (APA) are at increased risk for thrombosis; however, it is difficult to predict who will clot. This study tested the hypothesis that peak D-dimer level measured routinely during follow-up identifies whether a hypercoagulable state is developing and, therefore, the patient is at increased risk for thrombosis. Design, setting, participants, & measurements: One hundred consecutive patients who had SLE with recurrent activity (71% renal SLE) and were evaluated for or enrolled in the Ohio SLE Study were studied. D-dimer testing was done annually and usually at SLE flare or other serious illness. When D-dimer was elevated, evaluation for thrombosis (large vessel, small vessel, or Libman-Sacks) was undertaken. Mean follow-up was 37.5 ± 15 SD months. Results: Of those with peak D-dimer 2.0 μg/ml (n = 36), 42% thrombosed, 76% had APA. The most common causes of elevated D-dimer in the absence of demonstrable thrombosis were SLE flare and systemic infection. D-dimer levels were usually elevated for several months before thrombosis. Conclusions: Patients with SLE and normal D-dimer levels are at low risk for thrombosis, irrespective of APA status. Those with persistent unexplained elevated D-dimer levels, particularly when >2.0 μg/ml, are at high risk for thrombosis.Keywords
This publication has 55 references indexed in Scilit:
- Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European AmericansAmerican Journal of Human Genetics, 2007
- d-Dimer and Duration of AnticoagulationNew England Journal of Medicine, 2007
- Fluctuation in self‐perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A –1019 G alleleArthritis & Rheumatism, 2006
- Is there a microangiopathic antiphospholipid syndrome?Annals Of The Rheumatic Diseases, 2006
- D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolismJournal of Thrombosis and Haemostasis, 2006
- Pulmonary disease in systemic lupus erythematosus and the antiphospholpid syndromeAutoimmunity Reviews, 2004
- Catastrophic Antiphospholipid SyndromeMedicine, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and DeathStroke, 1997
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985